Results 151 to 160 of about 6,056,925 (239)

ФÑзÑоÑеÑапевÑиÑÐ½Ñ Ð¼ÐµÑоди лÑкÑÐ²Ð°Ð½Ð½Ñ Ñ Ð¿Ð°ÑодонÑологÑÑ

, 2014
С. І. Бойцанюк, М. А. Лучинський, В. В. Сопотніцька   +2 more
openalex   +2 more sources

In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations

Molecular Oncology, EarlyView.
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra, Shamsudheen Karuthedath Vellarikkal, Lixia Li, Hong Sun, Khoa Nguyen, Amber Montano, Suchitra Natarajan, Federica Piccioni, Alex Michael Tamburino, Xin Yu, Aleksandra Katarzyna Olow   +10 more
wiley   +1 more source

Dietary exposure to N-nitrosamines and their precursors: an age-stratified assessment. [PDF]

Sci Rep
Zapico A, Herrero-Morin D, Arboleya S, de Los Reyes-Gavilán CG, Gueimonde M, González S.   +5 more
europepmc   +1 more source

Ðплив ÑиÑÑÐµÐ¼Ð½Ð¸Ñ ÑмÑÐ½Ð½Ð¸Ñ Ð¿Ð¾ÑÑÑÐµÐ½Ñ Ð½Ð° пеÑебÑг генеÑалÑзованого паÑодонÑиÑÑ Ñ ÑвоÑÐ¸Ñ Ð½Ð° ÑевмаÑоÑдний аÑÑÑиÑ

, 2015
І. П. Мазур, С. І. Сміян, І. І. Білозецький, І. І. Свистун   +3 more
openalex   +2 more sources

Effect of chemotherapy on passenger mutations in metastatic colorectal cancer

Molecular Oncology, EarlyView.
Changes in passenger mutation load and predicted immunotherapy response after chemotherapy treatment. Tumor cells rich with passenger mutations have increased sensitivity to chemotherapy. Correlation of passenger mutations with neoantigen load suggests highly mutated clones promote a more effective response to immunotherapy, and therefore, first‐line ...
Marium T. Siddiqui, Matthew A. Cottam, Muhammad Bilal Mirza, Keeli B. Lewis, Kristen K. Ciombor, Mary Kay Washington, Kamran Idrees   +6 more
wiley   +1 more source

HbA1c underperforms in identifying abnormal glucose tolerance in the presence of G6PD deficiency: Insight from the Africans in America study. [PDF]

PLoS One
Bentley AR, Ntabadde K, Kabeza CB, Ekoru K, DuBose CW, Sacks DB, Adeyemo AA, Rotimi CN, Sumner AE.   +8 more
europepmc   +1 more source

ÐÑобливоÑÑÑ Ð´ÑагноÑÑики Ñа комплекÑне лÑкÑÐ²Ð°Ð½Ð½Ñ ÑвоÑÐ¸Ñ Ñз ÑÑÑÑÑгÑÑним ÑепÑиÑом.

, 2013
M. M. Stets, Л. О. Харченко, Т. М. Галига   +2 more
openalex   +2 more sources

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

Molecular Oncology, EarlyView.
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son, Lily L. Remsing Rix, Bin Fang, Eric A. Welsh, Nicole V. Bremer, Valentina Foglizzo, Paola Roa, Nickole Sigcha‐Coello, Yi Liao, Eric B. Haura, Alexander Drilon, John M. Koomen, Emiliano Cocco, Uwe Rix   +13 more
wiley   +1 more source

Rational design and synthesis of new acetamide-indole-benzo[<i>d</i>]imidazole-carboxylic acid hybrids as dual PTP1B/α-glucosidase inhibitors. [PDF]

RSC Adv
Dastyafteh N, Ghafouri SN, Mollazadeh M, Motamedi Shakib N, Halimi M, Hosseini S, Mojtabavi S, Faramarzi MA, Larijani B, Amanlou M, Mohammadi-Khanaposhtani M, Mahdavi M.   +11 more
europepmc   +1 more source

ÐногокÑиÑеÑиалÑÐ½Ð°Ñ Ð¾Ð¿ÑимизаÑÐ¸Ñ ÑÑаÑионаÑнÑÑ Ñежимов ÐÐС Ñ Ð¿Ð¾Ð¼Ð¾ÑÑÑ Ð³ÐµÐ½ÐµÑиÑеÑкого алгоÑиÑма и алгоÑиÑма ÑÐ¾Ñ ÑаÑÑиÑ

, 2016
Александр Чернавин
openalex   +1 more source